Article
Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles.
Genome medicine - 4 Jan 2021
Walker Rosie M, Vaher Kadi, Bermingham Mairead L, Morris Stewart W, Bretherick Andrew D, Zeng Yanni, Rawlik Konrad, Amador Carmen, Campbell Archie, Haley Chris S, Hayward Caroline, Porteous David J, McIntosh Andrew M, Marioni Riccardo E, Evans Kathryn L
Abstract excerpt
BACKGROUND: The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer's disease, whilst the ε2 allele confers protection. Previous studies report differential DNA methylation of APOE between ε4 and ε2 carriers, but associations with epigenome-wide methylation have not previously been characterised. METHODS: Using the EPIC array, we investigated epigenome-wide differences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
